Efficacy and safety of immunotherapy plus chemotherapy in elderly patients with advanced gastric cancer: a retrospective study. (PubMed, Jpn J Clin Oncol) - Oct 19, 2026 - "No clear age-related differences in survival outcomes or safety were observed with first-line immunotherapy plus chemotherapy in this study. However, elderly patients had higher treatment discontinuation and lower subsequent therapy rates, highlighting the importance of individualized dose adjustment and timely disease assessment and close monitoring."
Journal • Retrospective data • Gastric Cancer • Oncology • Solid Tumor • HER-2
|
|
Hirofumi Yasui; Kentaro Yamazaki; Kotoe Oshima; Kunihiro Fushiki; Naoya Ishibashi; Satoshi Hamauchi; Takahiro Tsushima; Takeshi Kawakami; Tomoya Yokota; Yusuke Onozawa
|